RRD International, LLC Release: FDA And Industry Veteran To Provide High-Level Regulatory And Clinical Guidance To Biotechnology And Pharmaceutical Companies

RRD International, LLC (RRD), a product development company supporting the regulatory and clinical needs of pharmaceutical and biotechnology companies, announced today the appointment of Curtis L. Scribner, M.D., as Senior Vice President of Medical and Regulatory Affairs. In this newly created position, Dr. Scribner will provide strategic leadership of product development programs for the expanding number of RRD partners which include both start-up biotechnology and larger pharmaceutical companies. He will be based in the San Francisco Bay Area and report directly to Charles W. Finn, Ph.D., Chief Executive Officer of RRD.

MORE ON THIS TOPIC